Clinical Trials Browser

Phase 2 × Lung Neoplasms × lenvatinib × Clear all

NCT05384015 2026-04-30

PEERS

Phase 2 Active not recruiting

Lung Neoplasms

NCT01877083 2019-08-13

Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung

Phase 2 Completed

25 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms